We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBP icon
5626
XBP Global Holdings
XBP
$34.4M
$2K ﹤0.01%
15
+14
+1,400% +$1.42K
YYY icon
5627
Amplify CEF High Income ETF
YYY
$742M
$2K ﹤0.01%
139
– –
ZVIA icon
5628
Zevia
ZVIA
$105M
$2K ﹤0.01%
349
-3,175
-90% -$12.9K
ABTC
5629
American Bitcoin Corp
ABTC
$504M
$2K ﹤0.01%
1
– –
SHRY icon
5630
First Trust Exchange-Traded Fund VI First Trust Bloomberg Shareholder Yield ETF
SHRY
$16.5M
$2K ﹤0.01%
62
– –
NTRP icon
5631
NextTrip
NTRP
$23.1M
$2K ﹤0.01%
145
+60
+71% +$1.31K
CSCI
5632
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$2K ﹤0.01%
120
+63
+111% +$1.21K
AIFU
5633
AIFU Inc
AIFU
$219M
$2K ﹤0.01%
1
-10
-91% -$20.3K
MTVA
5634
MetaVia Inc
MTVA
$7.33M
$2K ﹤0.01%
2
-4
-67% -$4.89K
BLNE
5635
Beeline Holdings
BLNE
$36.4M
$2K ﹤0.01%
45
+4
+10% +$424
CYCU
5636
Cycurion Inc
CYCU
$6.75M
$2K ﹤0.01%
6
+5
+500% +$1.48K
ASBP
5637
Aspire Biopharma
ASBP
$9.86M
– –
0
– –
YOTA
5638
DELISTED
Yotta Acquisition Corporation Common Stock
YOTA
$2K ﹤0.01%
+185
New +$1.82K
HCVI
5639
DELISTED
Hennessy Capital Investment Corp. VI Class A Common Stock
HCVI
$2K ﹤0.01%
+241
New +$2.33K
ACHL
5640
DELISTED
Achilles Therapeutics
ACHL
$2K ﹤0.01%
806
+785
+3,738% +$2.22K
HCP
5641
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$2K ﹤0.01%
+56
New +$1.93K
PPYA
5642
DELISTED
Papaya Growth Opportunity Corp. I Class A Common Stock
PPYA
$2K ﹤0.01%
+218
New +$2.18K
PFTA
5643
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
$2K ﹤0.01%
+159
New +$1.55K
LEV
5644
DELISTED
The Lion Electric Company
LEV
$2K ﹤0.01%
809
-9,116
-92% -$39K
CBRG
5645
DELISTED
Chain Bridge I Class A Ordinary Shares
CBRG
$2K ﹤0.01%
+216
New +$2.17K
MCAA
5646
DELISTED
Mountain & Co. I Acquisition Corp. Class A Ordinary Shares
MCAA
$2K ﹤0.01%
227
+199
+711% +$2.02K
FIACU
5647
DELISTED
Focus Impact Acquisition Corp. Unit
FIACU
$2K ﹤0.01%
248
-2
-0.8% -$20
BHACU
5648
DELISTED
Focus Impact BH3 Acquisition Company Units
BHACU
$2K ﹤0.01%
200
– –
ASCB
5649
DELISTED
A SPAC II Acquisition Corp. Ordinary Shares
ASCB
$2K ﹤0.01%
163
+153
+1,530% +$1.52K
PEGR
5650
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
$2K ﹤0.01%
205
– –
224 225
226
227 228

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.